Document is current
Any future updates will be listed below
-
Authors
Sodi, Andrea
Banfi, Sandro
Testa, Francesco http://orcid.org/0000-0002-1482-1577
Della Corte, Michele
Passerini, Ilaria
Pelo, Elisabetta
Rossi, Settimio
Simonelli, Francesca
,
- License Information
-
More Information
Article History
Received: 11 January 2021
Accepted: 11 May 2021
First Online: 4 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: AS reports receiving fees for serving on advisory boards from Novartis. FT reports receiving fees for serving on advisory boards and as a lecturer from Novartis. SB reports receiving fees for serving on advisory boards from Novartis, and funding from the Italian Telethon Foundation, Rome, Italy and from the Fondazione Roma, Rome, Italy. MDC reports receiving fees for serving on advisory boards from Novartis. IP reports receiving fees for serving on advisory boards from Novartis. EP reports receiving fees for serving on advisory boards from Novartis. SR reports receiving fees for serving on advisory boards from Novartis. FS reports serving as an advisory board member for Biogen and Novartis, and providing expert testimony for MA provider, AIM group, Uvet, Sifi, Bayern, Santhera, Alia Therapeutics, Allergan and 3Psolution.
